OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Hypertension in diabetes care: emerging roles of recent hypoglycemic agents
Atsushi Tanaka, Koichi Node
Hypertension Research (2021) Vol. 44, Iss. 8, pp. 897-905
Closed Access | Times Cited: 15
Atsushi Tanaka, Koichi Node
Hypertension Research (2021) Vol. 44, Iss. 8, pp. 897-905
Closed Access | Times Cited: 15
Showing 15 citing articles:
The need for screening, early diagnosis, and prediction of chronic kidney disease in people with diabetes in low- and middle-income countries—a review of the current literature
Cindy George, Justin B. Echouffo‐Tcheugui, Bernard G. Jaar, et al.
BMC Medicine (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 54
Cindy George, Justin B. Echouffo‐Tcheugui, Bernard G. Jaar, et al.
BMC Medicine (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 54
Seven‐action approaches for the management of hypertension in Asia – The HOPE Asia network
Kazuomi Kario, Yook Chin Chia, Saulat Siddique, et al.
Journal of Clinical Hypertension (2022) Vol. 24, Iss. 3, pp. 213-223
Open Access | Times Cited: 41
Kazuomi Kario, Yook Chin Chia, Saulat Siddique, et al.
Journal of Clinical Hypertension (2022) Vol. 24, Iss. 3, pp. 213-223
Open Access | Times Cited: 41
Associations of metabolic disorders with hypertension and cardiovascular disease: recent findings and therapeutic perspectives
Atsushi Tanaka, Koichi Node
Hypertension Research (2024) Vol. 47, Iss. 12, pp. 3338-3344
Closed Access | Times Cited: 9
Atsushi Tanaka, Koichi Node
Hypertension Research (2024) Vol. 47, Iss. 12, pp. 3338-3344
Closed Access | Times Cited: 9
Latest hypertension research to inform clinical practice in Asia
Kazuomi Kario, Masaki Mogi, Satoshi Hoshide
Hypertension Research (2022) Vol. 45, Iss. 4, pp. 555-572
Open Access | Times Cited: 19
Kazuomi Kario, Masaki Mogi, Satoshi Hoshide
Hypertension Research (2022) Vol. 45, Iss. 4, pp. 555-572
Open Access | Times Cited: 19
Recent understandings about hypertension management in type 2 diabetes: What are the roles of SGLT2 inhibitor, GLP-1 receptor agonist, and finerenone?
Kosuke Sawami, Atsushi Tanaka, Koichi Node
Hypertension Research (2023) Vol. 46, Iss. 8, pp. 1892-1899
Closed Access | Times Cited: 11
Kosuke Sawami, Atsushi Tanaka, Koichi Node
Hypertension Research (2023) Vol. 46, Iss. 8, pp. 1892-1899
Closed Access | Times Cited: 11
Blood pressure reduction with empagliflozin in Japanese patients with type 2 diabetes and cardiovascular diseases: a post-hoc sub-analysis of the placebo-controlled randomized EMBLEM trial
Atsushi Tanaka, Michio Shimabukuro, Hiroki Teragawa, et al.
Hypertension Research (2024) Vol. 47, Iss. 9, pp. 2295-2302
Closed Access | Times Cited: 4
Atsushi Tanaka, Michio Shimabukuro, Hiroki Teragawa, et al.
Hypertension Research (2024) Vol. 47, Iss. 9, pp. 2295-2302
Closed Access | Times Cited: 4
Update on Hypertension Research in 2021
Masaki Mogi, Tatsuya Maruhashi, Yukihito Higashi, et al.
Hypertension Research (2022) Vol. 45, Iss. 8, pp. 1276-1297
Open Access | Times Cited: 16
Masaki Mogi, Tatsuya Maruhashi, Yukihito Higashi, et al.
Hypertension Research (2022) Vol. 45, Iss. 8, pp. 1276-1297
Open Access | Times Cited: 16
2023 update and perspectives
Masaki Mogi, Atsushi Tanaka, Koichi Node, et al.
Hypertension Research (2023) Vol. 47, Iss. 1, pp. 6-32
Closed Access | Times Cited: 8
Masaki Mogi, Atsushi Tanaka, Koichi Node, et al.
Hypertension Research (2023) Vol. 47, Iss. 1, pp. 6-32
Closed Access | Times Cited: 8
Pretreatment body mass index affects achievement of target blood pressure with sodium-glucose cotransporter 2 inhibitors in patients with type 2 diabetes mellitus and chronic kidney disease
Shunichiro Tsukamoto, Kazuo Kobayashi, Masao Toyoda, et al.
Hypertension Research (2023) Vol. 47, Iss. 3, pp. 628-638
Closed Access | Times Cited: 5
Shunichiro Tsukamoto, Kazuo Kobayashi, Masao Toyoda, et al.
Hypertension Research (2023) Vol. 47, Iss. 3, pp. 628-638
Closed Access | Times Cited: 5
Candesartan protects against unilateral peripheral limb ischemia in type-2 diabetic rats: Possible contribution of PI3K-Akt-eNOS-VEGF angiogenic signaling pathway
Shimaa Khaled, Rania R. Abdеlaziz, Ghada M. Suddеk, et al.
International Immunopharmacology (2023) Vol. 116, pp. 109817-109817
Closed Access | Times Cited: 4
Shimaa Khaled, Rania R. Abdеlaziz, Ghada M. Suddеk, et al.
International Immunopharmacology (2023) Vol. 116, pp. 109817-109817
Closed Access | Times Cited: 4
Impact of diabetic status and contribution of office and home blood pressure across diabetic status for cardiovascular disease: the J-HOP study
Daisuke Suzuki, Satoshi Hoshide, Kazuomi Kario
Hypertension Research (2023) Vol. 46, Iss. 7, pp. 1684-1693
Closed Access | Times Cited: 4
Daisuke Suzuki, Satoshi Hoshide, Kazuomi Kario
Hypertension Research (2023) Vol. 46, Iss. 7, pp. 1684-1693
Closed Access | Times Cited: 4
Neuroimaging perspective in targeted treatment for type 2 diabetes melitus and sleep disorders
Karen M. von Deneen, Malgorzata Garstka
Intelligent Medicine (2022) Vol. 2, Iss. 4, pp. 209-220
Open Access | Times Cited: 7
Karen M. von Deneen, Malgorzata Garstka
Intelligent Medicine (2022) Vol. 2, Iss. 4, pp. 209-220
Open Access | Times Cited: 7
Who benefits from the blood pressure-lowering effects of SGLT2 inhibitors in patients with type 2 diabetes mellitus and chronic kidney disease? — Obese or non-obese?
Kazuki Shiina
Hypertension Research (2023) Vol. 47, Iss. 3, pp. 681-682
Open Access | Times Cited: 3
Kazuki Shiina
Hypertension Research (2023) Vol. 47, Iss. 3, pp. 681-682
Open Access | Times Cited: 3
Comparison of the clinical effect of empagliflozin on glycemic and non-glycemic parameters in Japanese patients with type 2 diabetes and cardiovascular disease treated with or without baseline metformin
Atsushi Tanaka, Michio Shimabukuro, Hiroki Teragawa, et al.
Cardiovascular Diabetology (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 3
Atsushi Tanaka, Michio Shimabukuro, Hiroki Teragawa, et al.
Cardiovascular Diabetology (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 3
Statin Use and Risk of Clinical Outcomes With Special Reference to Kidney Disease and Concurrent Medications in Patients With Diabetes Mellitus
Tomoyuki Kawada
The American Journal of Cardiology (2023) Vol. 205, pp. 523-524
Closed Access
Tomoyuki Kawada
The American Journal of Cardiology (2023) Vol. 205, pp. 523-524
Closed Access
